title: Reducing the risk of recurrences after pulmonary vein isolation: what is the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers?
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Steinberg
authors.forename: Naga Vamsi
authors.initials: NV
authors.lastname: Garikipati
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery; D017115:Catheter Ablation / Q000379:methods*; D003131:Combined Modality Therapy; D006801:Humans; D011667:Pulmonary Veins / Q000601:surgery*; D012307:Risk Factors; D055502:Secondary Prevention
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors